Ecopia BioSciences Inc.

Ecopia BioSciences Inc.

April 10, 2006 11:06 ET

Ecopia's Annual General Meeting of Shareholders to Take Place on April 11, 2006

MONTREAL, QUEBEC--(CCNMatthews - April 10, 2006) - Ecopia BioSciences Inc. (TSX:EIA). Mr. Francois Legault, Chairman of the Board of Ecopia and Dr. Pierre Falardeau, President and Chief Executive Officer, are pleased to invite Ecopia's shareholders to the Company's Annual General Meeting of shareholders. The event will take place on April 11, 2006 at the McGill Faculty Club & Conference Centre at 3450, McTavish Street in Montreal, at 10:00 a.m.

About Ecopia

Ecopia is finding novel anticancer therapies from soil-dwelling microorganisms that are one of the most prolific sources of drugs. Our current focus is to advance our flagship compound, ECO-4601, through the different stages of clinical trials. ECO-4601 is a novel small molecule that crosses the blood brain barrier and is effective in significantly inhibiting primary brain tumor growth and other types of cancers. Just like well-known chemotherapies such as doxorubicin and mitomycin C, ECO-4601 comes from microorganisms that live in common soil. However, unlike these drugs that were discovered many decades ago, ECO-4601 represents a new chemical class that is the fruit of a very unique drug discovery platform called the DECIPHER® technology. The common shares of Ecopia are listed on the TSX (symbol: EIA).

Contact Information